• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nuvalent, Inc. - Class A Common Stock (NQ:NUVL)

104.50 -3.52 (-3.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 993,472
Open 107.81
Bid (Size) 104.00 (100)
Ask (Size) 139.00 (300)
Prev. Close 108.02
Today's Range 104.48 - 108.69
52wk Range 63.55 - 113.02
Shares Outstanding 3,129,384
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
March 22, 2026
Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead program advancing in clinical trials for breast cancer. 
Via The Motley Fool
News headline image
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
March 16, 2026
Nuvalent develops targeted therapies for drug-resistant cancers, advancing clinical-stage candidates in precision oncology. 
Via The Motley Fool

Performance

YTD
+3.6%
+3.6%
1 Month
+6.6%
+6.6%
3 Month
-1.8%
-1.8%
6 Month
+11.9%
+11.9%
1 Year
+41.3%
+41.3%

More News

Read More
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
March 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
Why Did Nuvalent Stock Surge 15% Today? ↗
November 17, 2025
Via Stocktwits
News headline image
Earnings Scheduled For October 30, 2025 ↗
October 30, 2025
Via Benzinga
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
March 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
March 13, 2026
Via The Motley Fool
News headline image
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
February 19, 2026
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗
December 03, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗
December 03, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗
December 03, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗
December 03, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Gets Booted in Latest Fund Update ↗
November 19, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 17, 2025
Via Benzinga
News headline image
Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer ↗
November 17, 2025
Via Benzinga
News headline image
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
November 17, 2025
Via Benzinga
News headline image
Nuvalent Unveils A New Promise For Hard-To-Treat Lung Cancer ↗
November 17, 2025
Via Investor's Business Daily
News headline image
Wondering what's happening in today's after-hours session? ↗
November 14, 2025
Via Chartmill
News headline image
This Waste Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
November 12, 2025
Via Benzinga

Frequently Asked Questions

Is Nuvalent, Inc. - Class A Common Stock publicly traded?
Yes, Nuvalent, Inc. - Class A Common Stock is publicly traded.
What exchange does Nuvalent, Inc. - Class A Common Stock trade on?
Nuvalent, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nuvalent, Inc. - Class A Common Stock?
The ticker symbol for Nuvalent, Inc. - Class A Common Stock is NUVL on the Nasdaq Stock Market
What is the current price of Nuvalent, Inc. - Class A Common Stock?
The current price of Nuvalent, Inc. - Class A Common Stock is 104.50
When was Nuvalent, Inc. - Class A Common Stock last traded?
The last trade of Nuvalent, Inc. - Class A Common Stock was at 04/24/26 04:00 PM ET
What is the market capitalization of Nuvalent, Inc. - Class A Common Stock?
The market capitalization of Nuvalent, Inc. - Class A Common Stock is 327.02M
How many shares of Nuvalent, Inc. - Class A Common Stock are outstanding?
Nuvalent, Inc. - Class A Common Stock has 327M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap